We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+15.7%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$7.33B
AUM Growth
+$29.8M
Cap. Flow
-$960M
Cap. Flow %
-13.1%
Top 10 Hldgs %
34.8%
Holding
114
New
8
Increased
13
Reduced
67
Closed
12

Top Buys

Rank Stock Value
1
WFG icon
West Fraser Timber
WFG
+$137M
2
TRP icon
TC Energy
TRP
+$74.4M
3
SJR
Shaw Communications Inc.
SJR
+$49.5M
4
CVE icon
Cenovus Energy
CVE
+$27.5M
5
ABBV icon
AbbVie
ABBV
+$25.6M

Sector Composition

Rank Sector Weight
1 Financials 28.87%
2 Energy 16.87%
3 Communication Services 15.54%
4 Materials 12.56%
5 Technology 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GT icon
76
Goodyear
GT
$1.53B
$10.7M 0.15%
608,358
-126,950
-17% -$1.84M
FLR icon
77
Fluor
FLR
$7.16B
$9.63M 0.13%
416,894
-44,500
-10% -$865K
VT icon
78
Vanguard Total World Stock ETF
VT
$81B
$7.68M 0.1%
+78,900
New +$7.59M
CVE.WS
79
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$7.23M 0.1%
+1,817,777
New +$6.34M
FTS icon
80
Fortis
FTS
$27.8B
$6.03M 0.08%
139,050
-46,700
-25% -$1.91M
YTRA icon
81
Yatra Online
YTRA
$72.3M
$4.98M 0.07%
2,138,020
+500,020
+31% +$1.17M
PDS
82
Precision Drilling
PDS
$1.11B
$4.04M 0.06%
186,976
-62,517
-25% -$1.42M
SCHW
83
Charles Schwab
SCHW
$186B
$1.42M 0.02%
21,846
ING icon
84
ING
ING
$105B
$1.34M 0.02%
109,869
-560
-0.5% -$5.95K
MYOV
85
DELISTED
Myovant Sciences Ltd.
MYOV
$1.3M 0.02%
63,204
ARDX icon
86
Ardelyx
ARDX
$924M
$1.14M 0.02%
+172,300
New +$1.18M
SPRO icon
87
Spero Therapeutics
SPRO
$65.8M
$1.08M 0.01%
73,659
+5,559
+8% +$97.8K
HRTX icon
88
Heron Therapeutics
HRTX
$59.9M
$927K 0.01%
57,200
MET icon
89
MetLife
MET
$61.7B
$796K 0.01%
13,099
REPL icon
90
Replimune Group
REPL
$1.24B
$696K 0.01%
22,800
UNH icon
91
UnitedHealth
UNH
$344B
$688K 0.01%
1,850
IMV
92
DELISTED
IMV Inc. Common Shares
IMV
$560K 0.01%
17,000
V icon
93
Visa
V
$701B
$483K 0.01%
2,280
QNCX icon
94
Quince Therapeutics
QNCX
$30.1M
$341K ﹤0.01%
47
E icon
95
ENI
E
$80.6B
$321K ﹤0.01%
13,000
NUE icon
96
Nucor
NUE
$58.9B
$313K ﹤0.01%
3,900
DUK icon
97
Duke Energy
DUK
$93.1B
$299K ﹤0.01%
3,100
+500
+19% +$45.6K
RDS.B
98
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$291K ﹤0.01%
7,912
KMB icon
99
Kimberly-Clark
KMB
$33B
$282K ﹤0.01%
+2,025
New +$269K
ONCR
100
DELISTED
Oncorus, Inc.
ONCR
$275K ﹤0.01%
19,750
+8,750
+80% +$181K

Similar funds

Letko, Brosseau & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Letko, Brosseau & Associates held 114 positions worth $7.33B, up 0.41% from $7.3B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Letko, Brosseau & Associates withdrew a net $960M in Q1 2021, closing 12 positions and reducing 67 holdings. Its most notable exit was Norbord Inc., an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Letko, Brosseau & Associates opened a new position in West Fraser Timber worth $146M.

  • Letko, Brosseau & Associates's largest Q1 2021 buy was West Fraser Timber: 2,034,879 shares worth $146M.
  • Letko, Brosseau & Associates added most to TC Energy in Q1 2021, an estimated $74.4M increase.
  • Letko, Brosseau & Associates's biggest Q1 2021 reduction was Magna International, cutting an estimated $105M.
  • Letko, Brosseau & Associates fully exited Norbord Inc. in Q1 2021, selling an estimated $166M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $7.33B portfolio in Q1 2021.
  • Letko, Brosseau & Associates opened 8 new positions and closed 12 in Q1 2021.
  • Letko, Brosseau & Associates's portfolio value rose 0.41% quarter-over-quarter to $7.33B.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2021, filed 11 May 2021.